非类固醇抗炎药物使用和子宫内膜癌存活率:基于人口的挪威队列研究
Ala Jabri Haug1,2, Nathalie Støer3, Hilde Langseth3,4
1Akershus University Hospital, Lørenskog, Norway.
International journal of cancer
|February 24, 2025
概括
在被诊断为子宫内膜癌后使用阿司匹林和非阿司匹林NSAID可能会增加全因和癌症特定死亡的风险. 需要对生物机制进行进一步的研究.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 非类固醇抗炎药物 (NSAIDs) 在癌症患者的生存率方面显示出混合的结果.
- 关于包括阿司匹林在内的NSAIDs对子宫内膜癌 (EC) 结果的影响,存在相互矛盾的数据.
研究的目的:
- 调查阿司匹林和非阿司匹林NSAIDs (NA-NSAIDs) 使用与EC特定和全因死亡率之间的关联.
- 分析诊断前和诊断后的NSAID暴露与患者存活率的关系.
主要方法:
- 全国范围的队列研究将挪威的癌症和处方注册表 (2004-2018) 联系起来.
- 包括7751名EC患者;分析了诊断后和诊断前的NSAID使用情况.
- 多变量考克斯回归模型计算了死亡风险的危险比率.
主要成果:
- 阿司匹林使用与19%更高的全因死亡风险有关 (HR=1.19).
- 在诊断前和诊断后联合使用阿司匹林显示出更强的关联 (HR=1.35).
- 使用NA-NSAID与癌症特异性死亡风险增加有关,显示剂量反应关系 (HR=1.33在较高剂量).
结论:
- 在EC诊断后使用阿司匹林和NA-NSAID可能与死亡率增加有关.
- 这些关联背后的生物学机制需要进一步研究.
相关概念视频
01:21Cancer Survival Analysis
320
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
320
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
327
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
327